Kenneth W. Perry
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Kenneth W. Perry
Kenneth W. Perry is recorded as CFO at Regenerex Pharma, Inc. (RGPX). Regenerex Pharma, Inc. reported in an 8-K filed May 6, 2026 that Kenneth W. Perry was terminated as Chief Financial Officer, effective May 2, 2026. Regenerex Pharma, Inc. reported in an 8-K filed April 2, 2025 that Kenneth W. Perry was appointed Chief Financial Officer, effective March 31, 2025.
“Following the Committee's review and recommendation, the Independent Board of Directors approved the termination of Mr. Perry's employment for Cause, with notice of such termination delivered on May 2, 2026.”
“Effective March 31, 2025, Mr. Kenneth W. Perry has been appointed to serve as Chief Financial Officer for the company”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2025-03-31–present
-
2025-03-31–2026-05-02
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Regenerex Pharma, Inc.
Other people whose current roles at this company are on record from its filings.
- Gregory P. Pilant CEO, Chairman, Board Member
- Brent Wilson CFO
- Deborah L. Pilant CFO
- Don E. Ray CFO
- Lee Ori COO, Board Member
- Troy Thuet COO
- Dr Lee Ori Board Member
- J. Kenneth Hazen Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.